cro.directory
← Compare landing

ProSciento vs Scimega Research

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryProScientoScimega Research
SummarySpecialized CRO focused on metabolic diseases (obesity, diabetes, MASLD/MASH, cardiovascular, chronic kidney disease) with two decades of expertise, a nationwide registry of 180,000+ participants, and full-service clinical development capabilities from Phase 1 through Phase 3.Canadian oncology-focused CRO running Phase 1, 2 and 3 trials through privileged site relationships across Canada. Offers Reverse Feasibility, Health Canada CTA/IND strategy, provincial ethics approval support and CRA monitoring for small and mid-sized biopharma sponsors.
Services
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Regulatory Affairs
ModalitiesData not yet provided.Data not yet provided.
Indications
  • Metabolic
  • Cardiovascular
  • Nephrology
  • Oncology
Phases
  • Phase I
  • Phase II
  • Phase III
  • Phase I
  • Phase II
  • Phase III
Sourcing models
  • Full-Service Outsourcing (FSO)
Data not yet provided.
Locations
  • Headquarters, Chula Vista, California, United States
  • Laval, Laval, Québec, Canada
CertificationsData not yet provided.Data not yet provided.

Find similar companies

ProSciento alternatives · Scimega Research alternatives

Markdown mirror: /compare/prosciento/scimega.md